Lantheus Holdings (STU:0L8) EPS (Basic): €3.63 (TTM As of Mar. 2026)


STU:0L8 Lantheus Holdings Inc STU:0L8
86 GF Score
Price €92.30
GF Value €79.94
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Lantheus Holdings EPS (Basic)?

Lantheus Holdings STU:0L8 -0.97% 86 EPS (Basic) is €3.63 as of Mar. 2026. GuruFocus rates STU:0L8 with a GF Score™ of 86/100 and a GF Value™ of €79.94 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Lantheus Holdings's basic earnings per share (Basic EPS) for the three months ended in Mar. 2026 was €1.58. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was €3.63.

Lantheus Holdings's EPS (Diluted) for the three months ended in Mar. 2026 was €1.56. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was €3.58.

Lantheus Holdings's EPS without NRI for the three months ended in Mar. 2026 was €0.81. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was 4.68.

During the past 12 months, Lantheus Holdings's average EPS without NRIGrowth Rate was -8.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 12.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 80.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 27.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Lantheus Holdings's highest 3-Year average EPS without NRI Growth Rate was 139.80% per year. The lowest was -24.30% per year. And the median was 25.60% per year.

Lantheus Holdings  (STU:0L8) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Lantheus Holdings EPS (Basic) Related Terms

Lantheus Holdings EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Lantheus Holdings's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lantheus Holdings EPS (Basic) Chart

Lantheus Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.94 0.39 4.39 4.32 2.96

Lantheus Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 1.00 0.35 0.70 1.58
STU:0L8
86GF Score
Lantheus Holdings Inc STU:0L8
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lantheus Holdings EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Lantheus Holdings's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(199.459-0)/67.489
=2.96

Lantheus Holdings's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(102.431-0)/64.736
=1.58

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of €3.63 mean?
Lantheus Holdings (STU:0L8) has a EPS (Basic) of €3.63 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Lantheus Holdings and its competitors.
Is Lantheus Holdings' EPS (Basic) too high?
Lantheus Holdings' current EPS (Basic) is €3.63. Overall, Lantheus Holdings has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Lantheus Holdings' EPS (Basic) compare to HIMS and ALKS?
Lantheus Holdings' EPS (Basic) of €3.63 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Lantheus Holdings and its competitors. Lantheus Holdings's current EPS (Basic) is €3.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lantheus Holdings stock overvalued right now?
Based on GuruFocus' analysis, Lantheus Holdings (STU:0L8) is currently considered Modestly Overvalued. The stock's GF Value™ is €79.94, compared to a current price of €92.30 — trading 15.5% above its estimated fair value. The current EPS (Basic) is €3.63. Lantheus Holdings' overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Lantheus Holdings (STU:0L8), the current EPS (Basic) is €3.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Lantheus Holdings (STU:0L8) Overvalued in 2026?

Based on GuruFocus' analysis, Lantheus Holdings stock appears to be overvalued. The current stock price of €92.30 is trading 15.5% above its estimated GF Value™ of €79.94. GuruFocus considers Lantheus Holdings to be Modestly Overvalued.

Key valuation signals for STU:0L8:

  • EPS (Basic): €3.63
  • GF Value™: €79.94 vs. price of €92.30 (15.5% above fair value)
  • GF Score™: 86/100 with 5 warning signs

No single metric tells the full story. See the STU:0L8 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lantheus Holdings Business Description

Other Exchanges LNTH:USA1LNTH:Italy
Address 201 Burlington Road, South Building, Bedford, MA, USA, 01730
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
86GF Score

Get the complete analysis for STU:0L8

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€92.30
Price
€79.94
GF Value